AbbVie said on Monday that it has struck a three-year deal with U.S. President Donald Trump's administration to reduce drug ...

Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP ...

According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...

After receiving a diagnosis of terminal cancer, he used his experience in public relations to draw attention to the ...

The drug price hikes that are helping drive the health affordability crisis will continue for the rest of President Trump's ...

The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest pact as part of its “Most Favored Nation” pricing initiative.

Johnson & Johnson reached a White House deal to lower U.S. drug prices under Trump’s most-favored-nation policy.

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...

AARP says Medicare’s new drug price negotiations could save seniors billions of dollars each year Average price cuts across ...

Oregon’s attorney general is suing six of the nation’s largest pharmaceutical companies and pharmacy benefit managers for ...

Drugmakers hike prices 350 drugs in January, including Pfizer's COVID-19 vaccine and hospital drugs, with a median increase of 4%.

More than a dozen pharmas have recently struck deals with the White House to lower drug prices. Nevertheless, drugmakers ...